Edwards Lifesciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 May 25 | SellCHF 93,288 | Daveen Chopra | Individual | 1,500 | CHF 62.19 | |
07 May 25 | SellCHF 16,531 | Wayne Markowitz | Individual | 268 | CHF 61.68 | |
06 Dec 24 | SellCHF 112,481 | Daveen Chopra | Individual | 1,750 | CHF 64.27 | |
06 Dec 24 | SellCHF 37,472 | Wayne Markowitz | Individual | 583 | CHF 64.27 | |
20 Aug 24 | SellCHF 75,007 | Daveen Chopra | Individual | 1,250 | CHF 60.01 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 722,482 | 0.123% |
Individual Insiders | 5,334,667 | 0.907% |
General Public | 61,282,969 | 10.4% |
Institutions | 520,559,882 | 88.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
69,132,036 | CHF 4.3b | 10.4% | 0.07% | |||
54,485,319 | CHF 3.4b | -0.18% | 0.06% | |||
33,210,879 | CHF 2.0b | 5.32% | 0.38% | |||
25,808,622 | CHF 1.6b | -1.74% | 0.07% | |||
13,647,341 | CHF 842.0m | 0.93% | 0.07% | |||
12,177,515 | CHF 751.3m | 107% | 0.09% | |||
9,775,276 | CHF 603.1m | 7.68% | 0.28% | |||
9,418,074 | CHF 581.0m | 373% | 0.65% | |||
9,408,479 | CHF 580.5m | -7.12% | 1.53% | |||
9,205,302 | CHF 567.9m | 18.1% | 0.06% | |||
8,664,916 | CHF 534.6m | 6.48% | 0.11% | |||
8,251,995 | CHF 509.1m | -3.35% | 0.04% | |||
8,146,278 | CHF 502.6m | 7.66% | 0.74% | |||
7,591,779 | CHF 468.4m | -2.12% | 0.77% | |||
7,509,650 | CHF 463.3m | 94,100% | 0.32% | |||
6,701,847 | CHF 413.5m | 10.9% | 0.13% | |||
6,505,227 | CHF 401.3m | 21.8% | 0.06% | |||
5,813,419 | CHF 358.7m | 55.7% | 0.61% | |||
4,800,000 | CHF 296.1m | 6.67% | 3.6% | |||
4,615,163 | CHF 284.7m | 25% | 1.2% | |||
4,524,804 | CHF 279.2m | 49.8% | 0.07% | |||
4,243,976 | CHF 261.8m | 476% | 0.47% | |||
4,220,318 | CHF 260.4m | -2.89% | 0.06% | |||
4,057,013 | CHF 250.3m | 34.6% | 0.18% | |||
4,042,863 | CHF 249.4m | 0% | no data |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/03/19 14:43 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Edwards Lifesciences Corporation is covered by 67 analysts. 32 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
James Francis Mainwaring | Atlantic Equities LLP |
David Rescott | Baird |
Ishan Majumdar | Baptista Research |